CareFusion Corp (CFN)

CFN (:Health Services) EQUITY
$59.91
neg -0.06
-0.10%
Today's Range: 59.91 - 60.17 | CFN Avg Daily Volume: 2,440,700
Last Update: 03/16/15 - 4:01 PM EDT
Volume: 18,647,412
YTD Performance: 0.00%
Open: $60.00
Previous Close: $59.97
52 Week Range: $37.76 - $60.40
Oustanding Shares: 204,279,051
Market Cap: 12,238,357,945
6-Month Chart
TheStreet Ratings Grade for CFN
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 0 0 0 0
Moderate Buy 0 0 0 0
Hold 8 8 8 8
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 3.00 3.00 3.00 3.00
Latest Dividend: 0.00
Latest Dividend Yield: 0.00%
Dividend Ex-Date: 12/31/69
Price Earnings Ratio: 0.00
Price Earnings Comparisons:
CFN Sector Avg. S&P 500
0.00 25.50 27.68
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
0.00% 0.00% 0.00%
GROWTH 12 Mo 3 Yr CAGR
Revenue 8.20 0.09 0.03
Net Income 8.30 0.43 0.13
EPS 14.00 0.83 0.22
Earnings for CFN:
EBITDA 0.86B
Revenue 3.84B
Average Earnings Estimates
Qtr (03/15) Qtr (06/15) FY (06/15) FY (06/16)
Average Estimate $0.67 $0.83 $2.89 $2.90
Number of Analysts 6 6 7 7
High Estimate $0.71 $0.89 $3.05 $3.02
Low Estimate $0.61 $0.70 $2.80 $2.70
Prior Year $0.60 $0.79 $2.36 $2.89
Growth Rate (Year over Year) 11.11% 5.27% 22.52% 0.30%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
It's like a big-league franchise with a fantastic farm team.
Cybersecurity, retail among the most fashionable.
The logic of owning the pure play is attractive.
There may be a wave of consolidation.
The market is rewarding HP's breakup. Here's why.
Hewlett-Packard's recent spin-off is a good idea.
Bearish
May 06, 2014 | 7:57 AM EDT
CFN lowered its number, Barclays said. Lighter revenue driven by weakness in the Medical Systems segment. $42 price target and Equal We...
Bearish
Dec 17, 2013 | 8:03 AM EST
CFN was downgraded from Neutral to Sell, Goldman Sachs said. Valuation call, based on a $36 price target. 
Bullish
Aug 29, 2013 | 7:40 AM EDT
CFN price target was boosted to $42 from $37 as margin expansion should lead to multiple expansion, said Citigroup.
Bullish
Sep 07, 2012 | 7:55 AM EDT
Coverage of CFN was started with a Buy rating, ThinkEquity said. $30 price target. Company can continue to deliver solid organic growth...

Columnist Conversations

FIBOCALL: Amgen (AMGN) last generated a long-term overbought condition on the Dec. 9 close of $169.39 The shar...
Today we are 24 days down which is equal to a prior decline in time and we are also testing the lower support....
This market is NOT in a downtrend, but it IS failing so far against key monthly resistance as discussed in Off...
The Conagra dip this morning pushed the stock back down to the $36.00 area. CAG powered past this heavy ...

REAL MONEY'S BEST IDEAS

Columnist Tweets

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.